Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 2;6(4):407–412. doi: 10.1111/1759-7714.12188

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Thoracic Cancer published by Tianjin Lung Cancer Institute and Wiley Publishing Asia Pty Ltd.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

PMC Copyright notice

(a) Survival of patients who received whole brain radiotherapy (WBRT) compared with those who did not in entire cohort. (b) Survival of patients who received systemic chemotherapy compared with those who did not. (c) Survival of patients who received epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) compared with those who did not. (a) , WBRT (N = 49); , No WBRT (N = 59) P = 0.037; (b) , Chemotherapy (n = 59); , No Chemotherapy (n = 49) P = 0.59 (c) , EGFR-TKIs (n = 42); , No EGFR-TKIs (n = 66) P = 0.001.

Inline graphic — (a) Survival of patients who received whole brain radiotherapy (WBRT) compared with those who did not in entire cohort. (b) Survival of patients who received systemic chemotherapy compared with those who did not. (c) Survival of patients who received epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) compared with those who did not. (a) , WBRT (N = 49); , No WBRT (N = 59) P = 0.037; (b) , Chemotherapy (n = 59); , No Chemotherapy (n = 49) P = 0.59 (c) , EGFR-TKIs (n = 42); , No EGFR-TKIs (n = 66) P = 0.001.